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Abstract
Memo is a conserved protein that was identified as an essential mediator of tumor cell motility induced by receptor tyrosine
kinase activation. Here we show that Memo null mouse embryonic fibroblasts (MEFs) are impaired in PDGF-induced
migration and this is due to a defect in sphingosine-1-phosphate (S1P) signaling. S1P is a bioactive phospholipid produced
in response to multiple stimuli, which regulates many cellular processes. S1P is secreted to the extracellular milieu where it
exerts its function by binding a family of G-protein coupled receptors (S1PRs), causing their activation in an autocrine or
paracrine manner. The process, termed cell-autonomous S1PR signaling, plays a role in survival and migration. Indeed, PDGF
uses cell-autonomous S1PR signaling to promote cell migration; we show here that this S1P pathway requires Memo. Using
vascular endothelial cells (HUVECs) with Memo knock-down we show that their survival in conditions of serum-starvation is
impaired. Furthermore, Memo loss in HUVECs causes a reduction of junctional VE-cadherin and an increase in sprout
formation. Each of these phenotypes is rescued by S1P or S1P agonist addition, showing that Memo also plays an important
role in cell-autonomous S1PR signaling in endothelial cells. We also produced conventional and endothelial cell-specific
conditional Memo knock-out mouse strains and show that Memo is essential for embryonic development. Starting at E13.5
embryos of both strains display bleeding and other vascular problems, some of the phenotypes that have been described in
mouse strains lacking S1PRs. The essential role of Memo in embryonic vascular development may be due in part to
alterations in S1P signaling. Taken together our results show that Memo has a novel role in the S1P pathway and that Memo
is needed to promote cell-autonomous S1PR activation.
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Introduction
Our group identified Memo (mediator of ErbB2-driven cell
motility) as a 34 kDa protein essential for robust breast cancer cell
motility in response to activation of several receptor tyrosine
kinases (RTKs)[1]. Memo knock-down (KD) tumor cells showed
decreased migration following treatment with epidermal growth
factor (EGF), heregulin (HRG) or fibroblast growth factor
(FGF)[1,2]. Memo is encoded by a gene that is found in all
kingdoms of life; Memo’s protein sequence is highly conserved[3].
In S. cerevisiae we have found that Memo has a role in invasive
growth, suggesting that a function in cell motility/invasion is
conserved across species. In mice, Memo is widely expressed in
most adult organs[4]. Using a conditional Memo knock-out (KO)
strain we have recently shown that Memo loss leads to reduced
life-span accompanied by elevated serum levels of vitamin D and
calcium and other phenotypes[4]. The exact in vivo physiological
role of Memo is still unknown, however, the dramatic effects of
Memo loss suggest that in addition to its role in migration, Memo
might be involved in other essential physiological processes.
Here we show that Memo null mouse embryonic fibroblasts
(MEFs) isolated from Memo fl/fl embryos[4] are also impaired in
platelet-derived growth factor (PDGF)-induced migration. Inter-
estingly, we found that this is due to a defect in sphingosine-1-
phosphate (S1P) signaling in MEFs lacking Memo. S1P is a
bioactive sphingolipid metabolite that is produced within cells
through phosphorylation of sphingosine, in a reaction catalyzed by
two sphingosine kinases (SphK1 and 22)[5–7]. S1P has a crucial
role in many physiological processes including vascular develop-
ment and lymphocyte trafficking[7,8]. S1P is secreted to the
extracellular milieu by several transporters[9] where it exerts its
biological function by binding a family of five G-protein coupled
receptors, S1PR1-5, that are widely expressed in most cells and
tissues. Many stimuli activate SphKs leading to the production and
secretion of S1P, which activates S1PRs in an autocrine or
paracrine manner. This process of cell-autonomous S1PR
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activation, also called ‘inside-out’ signaling, plays a role in, e.g.,
survival and migration[6,10]. Indeed, growth factors such as
PDGF, use autonomous signaling of the SphK1/S1PR1 axis to
promote cell migration[11–15].
S1P has an essential role in stabilizing blood vessels during
development[16,17] and is important for endothelial proliferation,
migration, angiogenesis and survival[18]. This prompted us to
examine Memo’s role in endothelial cells. Using vascular
endothelial cells (HUVECs) with Memo KD we show that survival
is impaired in conditions of low S1P, following serum-starvation
and, importantly, this phenotype can be rescued by S1P addition,
suggesting that Memo is required for cell-autonomous signaling.
We also produced conventional and endothelial cell-specific
conditional Memo KO mouse strains and show here that Memo
is essential for embryonic development. Starting at E13.5 embryos
of both stains display bleeding and other vascular problems, some
of the phenotypes that have been described in mouse strains
lacking SphKs or S1PRs[19–21]. Taken together our results
suggest that Memo has a novel role in the S1P pathway, namely in
promoting cell-autonomous S1PR signaling.
Materials and Methods
Ethics Statement
Animals were housed in a 12/12 hour light/dark cycle with
food and water provided ad libitum, and all animal samples were
obtained after sacrificing animals with CO2 inhalation. All animal
experiments were performed according to Ethical Principles and
Guidelines for Experiments on Animals (3rd edition 2005,
Switzerland) and approved by the Institutional Animal Care and
Use Committee, the FMI Animal Committee, following approval
by the Cantonal Veterinary Office Basel-Stadt (Permit number
2286).
Materials
D-erythro-sphingosine-1-phosphate (S1P) and D-erythro-sphin-
gosine were purchased from Enzo Life Sciences (Farmingdale,
NY). Recombinant human platelet-derived growth factor-BB
(PDGF-BB), recombinant human vascular endothelial growth
factor 165 (VEGF165) and mouse anti-His tag antibody were
sourced from R&D systems (Minneapolis, MN). SEW2871 and
fatty acid-free bovine serum albumin (BSA) was purchased from
Sigma (St. Louis, MO). VPC23019 and (R)-W146 were obtained
from Avanti Polar Lipids (Alabaster, AL). VPC96091 was kindly
provided by Kevin R. Lynch (University of Virginia). [c-32P] ATP
(3000 Ci/mmol) was obtained from Hartmann Analytic
(Braunschweig, Germany). Mouse anti-smooth muscle actin
(SMA) antibody (1A4) and anti-mouse CD31 rat antibody
(MEC13.3) was purchased from Sigma and BD biosciences (San
Diego, CA), respectively. Rabbit anti-VE cadherin antibody (#sc-
28644) and mouse anti-myc antibody (9E10) were obtained from
Santa Cruz Biotechnology. Alexa-Fluor 546 conjugated goat anti-
rat antibody, Alexa-Fluor 488 conjugated goat anti-rabbit
antibody and mouse anti-V5 antibody were obtained from
Invitrogen (Carlsbad, CA). Rabbit anti-phospho-ERK (p42/44
MAPK) antibody and rabbit anti-phospho-VEGFR2 antibody
(19A10) were obtained from Cell Signaling Technology (Boston,
MA). Mouse anti-a-tubulin antibody (DM1A) was purchased from
NeoMarkers (Fremont, CA). The anti-Memo monoclonal anti-
body was produced in house as described previously[2] and
recognizes human and mouse Memo.
Cell culture, transfection, virus production and infection
Mouse embryonic fibroblasts (MEFs) were generated from
E13.5 Memo fl/fl embryos, maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (FBS) (Sigma) and spontaneously immortalized by contin-
uous passaging. Human umbilical vein endothelial cells (HU-
VECs) were purchased from PromoCell (Germany) and main-
tained in Endothelial Cell Growth Medium (PromoCell).
HUVECs of passage 5-8 were used for all assays.
For deletion of Memo in MEFs, a retrovirus was produced using
the vector pMSCV-CreERT2-puromycin (a gift from Patrick
Matthias (FMI, Basel, Switzerland)) following the protocol
described in Yamaguchi et al.[22]. Memo fl/fl MEFs were infected
with the retrovirus and cultures were exposed 3 days to tamoxifen
to activate Cre and delete Memo.
To generate stable control and Memo KD in HUVECs the
following vectors were used. The shLacZ control vector was
produced cloning the sequences 59-CCGGGCGGCTGCCG-
GAATTTACCTTCTCGAGGGTAAATTCCGGCAGCCGCT-
TTTT-39/59-AATTAAAAAGCGGCTGCCGGAATTTACCCT-
CGAGAAGGTAAATTCCGGCAGCCGC-3 into the pLKO.1-
puro plasmid. Stocks of pLKO.1-puro vectors containing
different shRNA sequences targeting Memo were purchased
from Sigma (MISSION shRNA libraryTRCN0000122895 (sh1)
and TRCN0000122898 (sh2)).
For all lentiviral preparations, HEK293T cells were transiently
transfected with 8 mg pLKO.1-puro construct, 0.4 mg HDM-
tat16, 0.4 mg HDM-HgPM2, 0.4 mg pRC-CMV-RaII and 0.8 mg
HDM-VSV-G using polyethylenimine (PEI) (Polysciences Inc.,
Warrington, PA, USA) and incubated for 16 hours (h) at 37uC, at
which point the media was changed. Media containing viruses
were collected 72 h post-transfection, filter sterilized, and stored at
280uC. Cells were infected over-night at 37uC with lentiviral
particles at a multiplicity of infection (MOI) of 2 in the presence of
8 mg/ml polybrene (Sigma) for 24 h. The media was then changed
and the cells were incubated another 24 h at 37uC. Successfully
infected cells were selected using 500 ng/mL puromycin (Sigma).
To analyze interaction between Memo and SphK1, HEK293T
cells were transiently transfected with pcDNA3.1-myc-Memo[1]
and/or pcDNA3.1-V5-SphK1[15] using PEI and cultured for
48 h before harvesting.
Immunoprecipitation, His pull-down and western
blotting
Cells were lysed in NP-40 lysis buffer and subjected to
immunoprecipitation as described previously[2]. For His pull-
down assay, purified Memo or myc-Memo[23] was incubated with
purified His-SphK1 (a gift from Doriano Fabbro (NIBR, Basel,
Switzerland)) for 16 h at 4uC in pull-down assay buffer (50 mM
Tris, pH 7.5, 100 mM NaCl, 1 mM EDTA, 0.1% NP-40, 10%
glycerol, 20 mM imidazole, 1 mM phenylmethylsulfonyl fluoride,
10 mg/ml leupeptin, and 10 mg/ml aprotinin). The protein
mixture was incubated with Ni-NTA agarose (Qiagen) for 90
minutes at 4uC, washed three times with pull-down assay buffer
and the bound proteins were eluted from the agarose. Protein
lysates were immunoblotted as described previously[2].
Cell migration assay
The transwell migration of cells was determined by modified
Boyden chamber assays. Briefly, both sides of an 8 mm-pore
migration chamber (24-well format: BD Biosciences, San Diego,
CA) were coated with 25 mg/ml rat tail Type I collagen for MEFs
or 5 mg/ml fibronectin for HUVECs (both from Roche, Basel,
Memo Influences Cell-Autonomous S1PR Signaling
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Switzerland). Cells were starved in migration medium (MEFs -
overnight in DMEM containing 0.1% fatty acid-free BSA;
HUVECs- 4 h in MEM alpha containing 0.1% fatty acid-free
BSA) then harvested into the same medium, plated onto the top
well and allowed to migrate toward the lower well filled with
migration medium containing S1P, PDGF or VEGF. After 16 h
for MEFs or 4 h for HUVECs, cells migrated to the lower side of
the chamber were fixed with 4% PFA and stained with 0.1%
crystal violet. Images were taken at five different areas per well
using an Axiovert 200 microscope (Carl Zeiss, Go¨ttingen,
Germany) and the number of cells was counted. In experiments
with VPC96191 or VPC23019, harvested cells were incubated
with them for 60 min at 37uC prior to plating and the same
concentration of VPC96191 or VPC23019 was put in the lower
wells.
Quantitative real-time PCR (qPCR)
Total RNA was extracted from cells using the RNeasy Mini Kit
(Qiagen) and used to synthesize cDNA by reversed transcriprion
with Ready-to-go You-Prime First-Strand Beads (GE Healthcare,
Little Chalfont, UK) using oligos-dT(15) primers (Promega,
Fitchburg, WI). Quantitative real-time PCR was carried out using
specific primers listed in Table S1 with StepOne Real-Time PCR
System instrument and software (Applied Biosystems, Carlsbad,
CA). For each primer pair, a calibration curve was drawn and
used for the calculations. Expression values were normalized to the
value of mouse actin or human glyceraldehyde 3-phosphate
dehydrogenase (GAPDH).
Sphingosine kinase assay
SphK1 activity was measured according to Olivera et al.[24]
with modifications. Briefly, cells were harvested with the SphK
assay buffer (20 mM Tris, pH 7.5, 20% glycerol, 1 mM EDTA,
1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 10 mM
MgCl2, 5 mM sodium orthovanadate, 15 mM NaF, 10 mg/ml
leupeptin, and 10 mg/ml aprotinin) and freeze-thawed. Lysates
were centrifuged at 700 6 g for 10 min at 4uC to remove the
insoluble fraction and the supernatants were then centrifuged at
100,0006g for 60 min at 4uC to obtain the cytosolic fractions as
supernatants. Cytoplasmic extracts (10 mg protein) were incubated
for 30 min at 37uC in SphK assay buffer in the presence of 50 mM
D-erythro sphingosine, [c-32P] ATP (1 mM, 0.5 mCi), 10 mM
MgCl2 and 0.25% Triton X-100. Lipids were extracted by adding
800 ml chloroform/methanol/HCl (100:200:1, v/v), vortexing
1 min, adding 240 ml chloroform and 240 ml 2 M KCl, vortexing
5 min, and centrifuging at 4,0006g for 2 min. The lower organic
phase was dried, resuspended in chloroform/methanol/HCl
(100:200:1, v/v) and separated by TLC on silica gel 60 (Merck,
Germany) with chloroform/acetone/methanol/acetic acid/H2O
(10:4:3:2:1, v/v). Radioactive bands were visualized and quantified
using an imager, Typhoon 9400 (Amersham Biosciences, Little
Chalfont, UK).
Measurement of S1P levels
Cell culture media were harvested on ice, mixed immediately
with 1/20 volume of inhibitor cocktail (300 mM Tris-HCl pH 7.5
containing 40 mM Na2VO4, 80 mM pyrophosphate, 100 mM
NaF, 20 mM deoxypyridoxine, 800 mM glycerophosphate) and
frozen at 280uC. Cells were harvested into ice-cold methanol and
kept at 280uC. Embryos were freshly frozen at 280uC. Mouse
plasma was mixed with 10 times volume of ice-cold methanol and
kept at 280uC. Lipids were extracted and the level of S1P was
measured by LC-ECI-MS/MS analysis as described previous-
ly[25].
Proliferation and apoptosis assays
HUVECs were plated on 6-well plates and cultured in
Endothelial Cell Growth Medium (full media) for 48 h. After
washing twice with PBS, the cells were cultured in full media or
serum-free alpha MEM with or without S1P or VPC23019. After
24 h, cells attached to the dish were harvested and counted using
the Vi-CELL counter (Beckman Coulter). For apoptosis assays,
HUVECs were plated on 96-well plates and cultured in full media
for 48 h. After washing twice with PBS, the cells were cultured for
another 24 h with serum-free alpha MEM with or without S1P or
VPC23019. The ratio of apoptotic cells was determined with the
YO-PRO apoptosis assay kit (Invitrogen)[26].
In situ hybridization
The 1.15 kb CDS/39-UTR fragment of mouse Memo cDNA
(NCBI Reference Sequence NM_133771.2, nucleotides 347–
1493) was PCR amplified and used as a template for generating
riboprobes. Digoxigenin-labeled antisense and sense (control)
riboprobes were prepared using the DIG RNA Labeling Kit
(Roche, Basel, Switzerland). Mouse embryos were fixed in 4%
PFA in PBS, and embedded in paraffin. Hybridization of the
sections (5 mm thick) was performed with the Discovery XT
Staining Module (Ventana Medica Systems S.A.). Hybridized
probe-signals were visualized using DIG Nucleic Acid Detection
Kit (Roche) and counterstained with Methyl green.
Generation of Memo mutant mice
We generated conventional and conditional Memo KO mice by
gene targeting. For this, we cloned a targeting construct containing
a 59 homology arm, three loxP recombination sites, exon 2 (E2), a
FRT-flanked Pgk-Neomycin resistance (NEO) cassette, and a 39
homology arm (Figure S4A). The targeting construct was
linearized and introduced in 129/Ola embryonic stem (ES) cells
by electroporation. An ES clone that had undergone homologous
recombination was selected and confirmed by PCR and Southern
blot analysis. To generate conventional Memo KO mice, the
mutant ES clone containing the targeted allele was transiently
transfected with the vector expressing cre recombinase (pCMV-
CRE; gift from Patrick Matthias, FMI, Basel, Switzerland) to
delete the floxed fragment (Figure S4A). An ES clone containing
the deleted allele was selected and used to establish chimeric mice.
These mice were further bred as Memo +/2 mice. Conditional
Memo KO mice were generated previously[4]. For this, chimeric
mice were established using the mutant ES clone containing the
targeted allele (Figure S4A), crossed with FLP deleter transgenic
mice (gift from Silvia Arber, FMI, Basel, Switzerland) to delete the
NEO cassette and further bred as Memo fl/+.
Both lines were maintained in the background of four times
backcrossed to C57BL/6JRccHsd (Stock number 43) from Harlan
Laboratory (Netherland). Genotyping of these lines was performed
using primer F (59-CCCTCTCATCTGGCTTGGTA-39) and
primer R (59-GCTCGATATGCTCACAAAGG-39) that recog-
nize the sites indicated in Figure S4A. To produce Memo
endothelial cell-specific Memo KO (ECKO) mice, Memo floxed
mice were crossed with Tie2Cre transgenic mice in a C57BL/6
background[27] (kindly provided by Tatiana Petrova, ISREC,
Lausanne). Conversion of the floxed allele into the deleted allele in
the presence of the Tie2Cre allele was confirmed (Figure S5A, lane
3).
Immunohistochemical analysis
For immunostaining of sections, embryos were fixed in 4% PFA
in PBS and embedded in paraffin. Sections (3 mm thick) were
Memo Influences Cell-Autonomous S1PR Signaling
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stained with the Discovery XT Staining Module (Ventana Medica
Systems S.A.). For whole-mount immunostaining, yolk sacs were
fixed in 4% PFA in PBS, washed in PBS and incubated with
blocking solution (1% skim milk, 0.1% Triton X-100 in PBS).
Staining was performed by incubating tissues with anti-CD31 rat
antibody in blocking solution, followed by incubation with Alexa-
Fluor 546 conjugated anti-rat antibody in blocking solution.
Electron microscopy
Forelimbs were taken from embryos and fixed overnight at 4uC
in 2% PFA and 2% glutaraldehyde in 0.1 M Na-cacodylate buffer
(pH 7.4). They were then rinsed for 365 min with 0.1 M Na-
cacodylate buffer (pH 7.4) and postfixed with 0.1 M Na-cacodyl-
ate buffer containing 1.5% potassium ferrocyanide and 1%
osmium tetroxide for 30 min, immediately followed by treatment
in 1% osmium tetroxide in ddH2O for 30 min. To enhance
contrast, after 5 rinses in ddH2O, forelimbs were stained en bloc
with 1% aqueous uranyl acetate for 30 min. After dehydration
with ethanol, samples were rinsed in propylene oxide and
embedded in Embed812 resin (EMS). Blocks were trimmed
perpendicular to the finger buds, and ultrathin sections (30–
50 nm) were prepared with a Leica Ultracut EM UC7, collected
on Formvar coated copper slot grids, and stained with uranyl
acetate and Reynold’s lead. Images were acquired on a CM10
(FEI, Eindhoven) at 80 kV equipped with a side-mounted digital
camera (Veleta, Olympus).
Immunofluorescent staining
HUVECs were grown to confluency, washed twice with PBS
and cultured for another 6 h in full media (Endothelial Cell
Growth Medium) or serum-free alpha MEM with or without S1P
or VPC23019. Cells were then fixed in 4% PFA in PBS (+) (PBS
containing 0.5 mM Mg++ and 1 mM Ca++) for 5 min at room
temperature, permeabilized in 0.2% Triton X-100 in PBS (+) for
8 min at 4uC, and incubated with rabbit anti-VE cadherin
antibody in PBS (+) containing 5% skim milk overnight at 4uC.
After washing 3 times in PBS (+), the slides were incubated with
Alexa-Fluor 488 conjugated goat anti-rabbit antibody for 1 h at
room temperature, washed 3 times in PBS (+) and mounted in
ProLong Gold Antifade Reagent with DAPI (Invitrogen). Images
were taken using LSM700 confocal microscope (Carl Zeiss).
HUVECs cellular spheroid sprouting assay
HUVECs were harvested and resuspended in Endothelial Cell
Basal Medium (EBM) (PromoCell) containing 20% Methocel and
20% charcoal stripped fetal bovine serum (cs-FBS) (Invitrogen) at a
density of 4 cells/ml. 800 cells (200 ml)/well were seeded into non-
adherent round-bottom 96-wells and cultured overnight to allow
spheroid formation. Spheroids (40 spheroids per experimental
point) were collected by centrifugation at 1,200 rpm for 5 min and
resuspended in 200 ml of 60% Methocel, 40% cs-FBS, 40 ng/ml
VEGF165 and 3 U/mL heparin (Calbiochem). In some experi-
ments, SEW2871, VPC23019 and W146 were added to the
spheroid suspension. In parallel, the collagen solution was
prepared with rat tail Type I collagen (Roche) to give a final
concentration of 1.4 mg/ml on ice. The spheroid suspensions were
mixed 1:1 (v/v) with the collagen solution, rapidly transferred into
48-well plates and incubated at 37uC with 5% CO2. After 36 h,
spheroids were fixed with 4% formaldehyde and imaged with
Axiovert200 (Carl Zeiss). Quantification was performed by
counting the number of sprouts and measuring the cumulative
sprout length per spheroid.
Statistical analysis
Statistical significance was determined by unpaired two-tailed
Student’s t test.
Results
PDGF induced migration requires Memo to mediate cell-
autonomous S1PR signaling
Control and Memo KO mouse embryonic fibroblasts (MEFs)
were used to explore migration and signaling pathways. For these
experiments we used MEFs prepared from Memo fl/fl embryos[4].
Memo was deleted by infecting the cells with a CreERT2-
containing retrovirus, which allows tamoxifen (TAM) inducible
Memo deletion (Figure 1A). This system allows a comparison
between control and Memo KO MEFs from the same origin.
Memo protein was no longer detectable in Memo fl/fl MEFs 3 days
following TAM addition (Figure 1B). Treatment of control MEFs
with PDGF induced robust motility; in contrast Memo KO MEFs
migrated approximately 50% less (Figure 1C).
The response of fibroblasts to PDGF is well characterized and
PDGFR activation is known to stimulate multiple signaling
pathways[28]. An examination of ERK, AKT, and PLCc
activation in control and Memo KOMEFs revealed no differences
between the two cell lines (Figure 2A), suggesting that Memo does
not influence activation of these pathways. PDGF also stimulates
SphK1 and S1P production, and S1PR1 has been shown to be
required for PDGF-induced migration[11,12,29]. Thus, we
examined the role of cell-autonomous S1PR signaling in the
MEFs by treating cells with PDGF in the presence of VPC96091,
a SphK1 inhibitor[30], or with VPC23019, an S1PR1/3
antagonist. Both inhibitors significantly blocked PDGF-induced
migration of control MEFs (Figure 2B), showing that this pathway
is required. As shown in Figure 1C, Memo KO cells migrate less.
Interestingly, neither of the inhibitors influenced PDGF-induced
migration of the Memo KO MEFs (Figure 2B), suggesting that
cell-autonomous signaling of the SphK1/S1PR1 axis is not active
in these cells.
Next we analyzed the cells for changes that could explain the
altered cell-autonomous signaling. The migratory response of
control and Memo KO MEFs to exogenous S1P was the same
(Figure 2C) and S1P-induced ERK activation was also similar in
both cells lines (Figure 2D). There were no differences in the
expression level of Sphk2, S1pr1 and S1pr3 in Memo control and
KO MEFs (Figure S1A). Memo KO MEFs do, however, have
significantly higher levels of Sphk1 (Figure S1A) and SphK1 kinase
activity (Figure S1B) compared to control MEFs. Thus, these data
suggest SphK1 expression and activity, as well as S1PR signaling
are intact in Memo KO MEFs. Increased expression of SphK1
might reflect the action of the Memo KO cells to compensate for
the defects in cell-autonomous S1PR signaling. Finally, we
analyzed S1P production dynamics by measuring intracellular
and extracellular S1P levels in response to PDGF stimulation using
a mass spectrometric approach. Intracellular S1P levels signifi-
cantly increased within 15 min of PDGF treatment in both control
and Memo KO MEFs (Figure 2E upper panel), showing that the
pathway is intact. Indeed in the Memo KO MEFs S1P induction
was higher than in control cells, likely reflecting elevated SphK1
kinase activity in these cells (Figure S1B). Extracellular S1P was
detectable in the media of control and Memo KO MEFs in the
absence of PDGF treatment (Figure 2E, lower panel) and in
control cultures S1P levels were significantly increased after
15 min of PDGF treatment (Figure 2E, lower panel). In striking
contrast there was no increase in extracellular S1P in the media of
Memo KO MEFs (Figure 2E, lower panel), despite the robust
Memo Influences Cell-Autonomous S1PR Signaling
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induction of intracellular S1P. These results suggest that in the
absence of Memo, cells fail to export S1P in response to PDGFR
activation. Taken together the data suggest that the decreased
migration observed in the Memo KO MEFs might be due to a
defect in export of S1P or in the availability of S1P for cell-
autonomous signaling.
Memo knockdown endothelial cells have a defect in cell-
autonomous S1PR signaling
S1P is known to be important for endothelial proliferation,
migration, angiogenesis and survival[18], which prompted us to
examine Memo’s role in endothelial cells. For this, Memo knock-
down (KD) human umbilical vein endothelial cells (HUVECs)
were generated using lentiviral vectors expressing 2 different
shRNAs targeting Memo (shMemo#1 and shMemo#2). Both
vectors decreased Memo levels, with vector #2 having the
strongest effect (Figure 3A).
First, we examined migration of control and Memo KD
HUVECs in response to VEGF. Both control and Memo KD cells
robustly responded to VEGF (Figure S2A). We also observed no
differences in VEGFR2 phosphorylation or ERK activation
(Figure S2B) in response to VEGF when comparing control and
Memo KD cells. When cultured in full media containing serum
and growth factors, proliferation of control shLacZ cells and both
Memo KD cell lines was the same (Figure 3B, left panel). When
cells were cultured in serum-free media for 24 h, however, there
were significantly fewer live cells in Memo KD cultures (Figure 3B,
right panel). Serum is a major source of S1P, suggesting that these
results might reflect a problem with cell-autonomous S1PR
signaling in the absence of Memo. To examine this result further,
cultures were exposed to serum-free media in the presence or
absence of the S1PR1/3 antagonist, VPC23019. The number of
control cells was significantly lower when S1PR1/3 activity was
blocked (Figure 3C), pointing to a role for cell-autonomous S1PR
signaling for proliferation or survival of HUVECs in conditions of
low serum. In contrast, while there were fewer cells in the Memo
KD cultures (as in Figure 3B), the addition of the S1PR1/3
antagonist did not cause a further decrease in cell number
(Figure 3C).
The preceding results suggest that cell-autonomous S1PR1/3
activity is missing in the absence of Memo. To test this hypothesis,
we examined the effect of exogenous S1P addition in serum-free
conditions. There was no increase in cell number in the control
cultures, while the number of Memo KD cells was significantly
increased, up to the level of control, when S1P was added
(Figure 3C, S1P bars). We also performed YO-PRO assays to
check if apoptosis was responsible for the lower cell number. After
24 h of serum-free conditions, approximately 30% of control
shLacZ cells were apoptotic, while there were significantly more
apoptotic cells (45%) in the Memo KD cultures (Figure 3D, white
bars). VPC23019 treatment significantly increased cell death, to
40% in control cultures, but had no effect on Memo KD cultures
(Figure 3D, gray bars). The addition of S1P to control shLacZ cells
had no effect on apoptotic-cell number, while S1P significantly
increased survival of Memo KD cultures (8% decrease in
apoptotic cells) (Figure 3D, black bars). These results clearly show
that in serum-limiting conditions HUVECs rely at least in part on
endogenous S1P and S1PR1/3 for their survival. This pathway is
lacking in Memo KD cells rendering them more sensitive to serum
withdrawal.
Next we examined if the Memo KD HUVECs have alterations
in expression and/or activity of S1P signaling molecules. First,
RNA levels of SphK1, SphK2, S1PR1 and S1PR3 were examined.
Control and Memo KD HUVECs have similar levels of SphK2 and
S1PR1, however, the Memo KD cells show a significant increase in
SphK1 and S1PR3 levels (Figure 4A). A western analysis with a
SphK1 specific antiserum[31] also showed higher SphK1 protein
levels, particularly in shMemo#2 KD cells (Figure 4B). To
indirectly measure SphK activity, the level of S1P was determined
using a mass spectrometric approach. In shMemo#2 KD cells,
there were significantly higher intracellular S1P levels, in
Figure 1. Memo KO fibroblasts have defects in PDGF-induced cell migration. A, Diagram for conditional Memo deletion in mouse
embryonic fibroblasts (MEFs). Immortalized Memo fl/fl MEFs were infected with a CreERT2-expressing retrovirus then treated with tamoxifen (TAM). B,
Western analyses for Memo levels in lysates from cells subjected to the indicated treatments; a-tubulin is the loading control. CreERT2-expressing
Memo fl/fl MEFs without or with TAM treatment were used as control and Memo knock-out (KO) MEFs, respectively. C, Transwell cell migration of
control and Memo KO MEFs was induced by PDGF (5 ng/ml) in serum-free media. Data were normalized to the average value for basal migration in
serum-free media and are presented as means 6 S.D. of five individual wells. Similar results were obtained in three independent experiments. **, p,
0.01; ***, p,0.001
doi:10.1371/journal.pone.0094114.g001
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comparison to the other cells (Figure 4C, left panel), potentially
due to higher SphK1 levels (Figure 4A–B). There were no
significant differences in exogenous S1P levels in the three cell lines
(Figure 4C, right panel). Next, we measured ERK signaling and
migration of the HUVECs in response to exogenous S1P
treatment. There was a rapid increase in ERK activity in response
to S1P, with the shMemo#2 KD cells showing a more robust and
prolonged increase in P-ERK levels compared to controls
(Figure 4D). S1P also stimulated migration, showing a significantly
stronger effect on the Memo KD HUVECs (Figure 4E). Thus,
exogenous S1P signaling is clearly intact in control and Memo KD
HUVECs. Indeed, the robust ERK activation and migration in
the Memo KD HUVECs might be due to the higher levels of
S1PR3 in these cells (Figure 4A).
Taken together, these data indicate that the survival phenotypes
in Memo KD HUVECs are not due to the defects in intracellular
Figure 2. Memo KOMEFs have defects in cell-autonomous S1PR signaling induced by PDGF. A, MEFs with the indicated treatments were
starved overnight and stimulated with PDGF (20 ng/ml) for 5 min. Western analyses were performed with the indicated antibodies. B, Transwell cell
migration of control and Memo KO MEFs was induced by PDGF (5 ng/ml) in serum-free media with or without the SphK1-specific inhibitor, VPC96091
(1 mM) or the S1PR1/S1PR3-specific antagonist, VPC23019 (1 mM). C, Transwell cell migration of control and Memo KO MEFs was induced by S1P
(5 nM) in serum-free media. In B and C, data were normalized to the average value for basal migration in serum-free media and are presented as
means 6 S.D. of three individual wells. Similar results were obtained in three independent experiments. D, Time course of ERK activation after S1P
treatment of control and Memo KO MEFs. Control and Memo KO MEFs were starved overnight and stimulated with 1 mM S1P for the indicated time.
Western analyses were performed with the indicated antibodies. E, S1P levels in control and Memo KO MEFs (upper panel) and their culture media
(lower panel) after PDGF-stimulation. Starved cultures were treated with PDGF (50 ng/ml) and at the indicated time points, culture media and cells
were harvested and analyzed for S1P levels by LC-ECI-MS/MS. Data are presented as means 6 S.D. of three individual plates. In E, p values were
calculated with respect to levels at the 0 time point. *, p,0.05; **, p,0.01; ***, p,0.001
doi:10.1371/journal.pone.0094114.g002
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S1P production or S1PR signaling stimulated exogenously, but are
likely to be caused by a defect in cell-autonomous S1PR activation.
In summary, these results suggest that HUVECs require cell-
autonomous S1PR signaling for survival in serum-limiting
conditions and that Memo has a direct or indirect role in this
pathway.
Deletion of Memo causes vascular defects in developing
embryos
Memo is expressed during development and is evident
throughout the embryos (Figure S3A–B) and in most organs from
adult mice[4]. In order to gain insight into the physiological
function of Memo, we generated Memo knock-out mouse strains.
Memo +/2 mouse strains were generated by conventional
technology (Figure S4A–C). Memo +/2 mice were healthy and
fertile; however, no living Memo 2/2 pups were born from Memo
+/2 intercrosses, indicating embryonic lethality. To determine the
timing and the cause of lethality, we analyzed embryos from Memo
+/2 intercrosses. As summarized in Table S2 and Figure 5A,
Memo 2/2 embryos died starting from embryonic day 13.5
(E13.5); no live Memo 2/2 embryos were found at E18.5
(Figure 5A). Starting at E13.5 (Figure 5B) Memo 2/2 (Memo KO)
embryos could be distinguished from controls (Memo +/+ and
Memo +/2) by four characteristics (summarized in Figure 5B); pale
yolk sacs (Figure 5C); pale embryos (Figure 5D); subcutaneous
edema (Figure 5D arrows); and bleeding, especially in the head
and neck regions (Figure 5D arrowheads). In addition, some of the
dead embryos were filled with blood (Figure 5D, E16.5).
Immunohistochemical studies revealed that Memo KO yolk
sacs were paler than controls, but had an apparently normal
vasculature organization with normal branched vessels (Figure 6A).
Embryos with bleeding phenotypes during late embryogenesis
often have defects in smooth muscle coverage of the vessels[32,33].
We examined the dorsal aorta, a large vessel, and observed slight
dilation, however, the vessels were covered by an intact layer of
smooth muscle cells (Figure 6B). These data indicate that typical
steps for vasculogenesis, angiogenesis and vascular maturation
appear to be normal in Memo KO embryos. Furthermore, EM
analysis showed no differences in the appearance of tight junctions
formed in capillary blood vessels between control and Memo KO
embryos (Figure 6C). Thus, although vasculature defects are likely
to contribute to the lethality observed in Memo KO embryos, we
could not identify an obvious reason for the bleeding phenotype.
Figure 3. Defects in S1P signaling in Memo knock-down endothelial cells. A, HUVECs were infected with retroviruses expressing control
shRNA (shLacZ) and two different shRNAs targeting Memo (shMemo#1 and #2). Western analyses were performed for Memo levels in the indicated
cells. B, Control and Memo knock-down (KD) HUVECs were cultured in full media for 2 days and then cultured for another 24 hours (h) in full media
(left panel) or serum-free media (right panel). Cells were counted and normalized to the average value at 2 days, which was set as 1. Data are
presented as means 6 S.D. of three individual plates. C, Effects of VPC23019 and S1P on survival of control and Memo KD HUVECs cultured in serum-
free media. Cells were counted after 24 h in serum-free media with or without 1 mM VPC23019 or 1 mM S1P and normalized to the average value
before switching to serum-free media, which was set as 1. Data are presented as means 6 S.D. of four individual plates. D, Ratio of apoptotic cells/
total cells after culturing 24 h in serum-free media with or without 1 mM VPC23019 or 1 mM S1P. Data are presented as means 6 S.D. of four
individual plates. *, p,0.05; **, p,0.01; ***, p,0.001
doi:10.1371/journal.pone.0094114.g003
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Memo acts within endothelial cells to regulate vascular
development
To specify a cell type that might be responsible for the
phenotypes, we generated Memo endothelial cell-specific KO
(ECKO) mice by crossing Memo fl/fl mice with Tie2Cre
transgenics[27]. Tie2Cre tg/2::Memo +/2 males were crossed
with Memo fl/fl females to generate Memo ECKO mice
(Figure 7A). Genomic PCR analysis of Memo in the offspring
revealed that Tie2Cre was active since crosses of Tie2Cre tg/2
::Memo +/2 with Memo fl/+ displayed a band corresponding to the
deleted allele (Figures S5A, lane 3). All possible genotypes were
identified in pups at postnatal day 21 (P21) (Figure S5A and
Figure 7B), however, the ratio of Tie2Cre tg/2::Memo fl/2 (Memo
ECKO) was only 10%, i.e., lower than the expected 25%,
suggesting that .50% of the Memo ECKO null embryos died
(Figure 7B). Surviving Memo ECKO pups developed into adults;
the only obvious abnormality was their lower weight compared to
control mice (Figure S5B).
A close examination of the embryos resulting from the Tie2Cre
tg/2::Memo +/2 x Memo fl/fl crosses revealed that some Memo
ECKO embryos had the same features as Memo 2/2 embryos,
including pale yolk sacs (Figure 7C), subcutaneous edema and
Figure 4. Analysis of S1P pathway and signaling in Memo knock-down endothelial cells. A, qPCR analysis for expression of SphK1, SphK2,
S1PR1 and S1PR3 mRNA in HUVECs. Data were normalized to the average value for the control and are presented as means 6 S.D. of three RNA
samples extracted from three plates. B, Western analyses were performed for SphK1 and Memo levels in the indicated cells; the two splicing variant
of SphK1 (a and b) are indicated. C, S1P levels in control and Memo KD HUVECs (left panel) and their culture media (right panel). After culturing 6 h in
serum-free media, culture media and cells were harvested and analyzed for the levels of S1P by LC-ECI-MS/MS. Data are presented as means6 S.D. of
three individual plates. D, Time course of ERK activation after S1P treatment of control and Memo KD HUVECs. HUVECs were starved for 6 h and
stimulated with 1 mM S1P for the indicated time. Cell lysates were prepared and western analysis was performed with the indicated antibodies. E,
Transwell cell migration of control and Memo KD HUVECs induced by S1P (100 nM) in serum-free media. The data were normalized to the average
value for basal migration without S1P stimulation and are presented as means 6 S.D. of five individual wells. *, p,0.05; **, p,0.01; ***, p,0.001
doi:10.1371/journal.pone.0094114.g004
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significant bleeding (Figure 7D). Moreover, the onset of these
features at E13.5 is similar to that seen in the Memo2/2 embryos.
These observations indicate that Memo plays an important role
within endothelial cells to regulate vascular development. The
different penetrance of lethality observed in the Memo ECKO
model suggests that there might be additional defects in the Memo
2/2 embryos, a result which is not unexpected considering that
Memo is widely expressed.
Memo knockdown endothelial cells have a defect in S1P-
mediated junctional localization of VE-cadherin and
exhibit hypersprouting
The observed phenotypes and the timing of their onset in
Memo KO and ECKO embryos have some of the features
described for embryos lacking proteins in the S1P signaling
network[19–21]. KO of S1PR1 in embryos as well as in
endothelial cells causes rapid embryonic death between E12.5
and E14.5, with prominent bleeding and defects in aortic vascular
smooth muscle cell coverage[20,34]. Neither the embryos with full
Memo KO nor the ECKO embryos have such a severe
phenotype. It is interesting, however, that starting at E13.5
S1PR2/S1PR3 double KO mice show partial embryonic lethality
and hemorrhaging, but have no obvious defects in smooth muscle
cell recruitment around large vessels[21]; characteristics that are
quite similar to those observed in embryos from Memo KO and
ECKO.
S1PR1 was recently shown to be important for stabilization of
VE-cadherin at endothelial junctions[16,17]. In the final exper-
iments we examined the impact of Memo loss on endothelial
junctions in the HUVEC model. Immunofluorescent (IF) staining
revealed that control and Memo KD cells show similar levels of
VE-cadherin positive junctions when cultured in full medium
(Figure 8A), which is consistent with the in vivo EM results
(Figure 6C). Notably, however, after culturing 6 h in serum-free
medium there was a dramatic loss of VE-cadherin staining in the
junctions of the Memo KD HUVECs, while VE-cadherin staining
in control cultures was unaltered (Figure 8A, -). This is likely to be
due to VE-cadherin relocalization and not to its loss since the level
of VE-cadherin in control and Memo KD cells in serum-free
medium is the same (Figure S6A). Addition of the S1PR1/3
antagonist VPC23019 reduced the signal of junctional VE-
cadherin in control cultures, but had no obvious effect on Memo
KD HUVECs (Figure 8A, VPC23019). Conversely, exogenous
S1P rescued the phenotype of Memo KD cells, but had no impact
on VE-cadherin staining in control cultures (Figure 8A, S1P).
These results show that in control HUVECs cell-autonomous
S1PR signaling is required for stabilizing junctional VE-cadherin
Figure 5. The phenotypes of control and Memo KO embryos. Memo +/2 males and females were mated and the phenotypes of the Memo
2/2 (Memo KO) embryos were analyzed. A, Percentage of Memo KO embryos found dead with respect to total number of Memo KO embryos. B,
percentage of living Memo KO embryos showing the indicated abnormality with respect to total number of living Memo KO embryos. In A and B,
total sample numbers (n) for each stage are indicated at the bottom of each panel. C, Whole-mount view of control and Memo KO yolk sacs at E14.5.
Scale bar, 4 mm. D, Whole-mount view of control and Memo KO embryos from E14.5 to E16.5. The sites of edema and bleeding frequently observed
in Memo KO embryos are indicated as arrows and arrowheads, respectively. The Memo KO embryos shown in C and D were alive, except for E16.5.
Scale bars, 4 mm. In all images, Memo KO is presented with the littermate control.
doi:10.1371/journal.pone.0094114.g005
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in conditions with little or no exogenous S1P. Moreover, the
Memo KD HUVECs have a defect in this pathway and this is
rescued by exogenous S1P.
Hypersprouting of the vascular network has been observed
when vascular junctions are destabilized due to defective S1PR1
signaling[16,17]. To examine if Memo loss affects sprouting, we
monitored sprout formation from HUVEC multicellular spheroids
in S1P-reduced conditions. Spheroids of Memo KD HUVECs
gave rise to sprouts significantly more frequently and the total
sprout lengths were longer compared to control spheroids
(Figure 8B–C). Importantly the addition of the S1PR1-specific
agonist SEW2871[35] lowered the number and the length of the
sprouts in Memo KD spheroids back to the levels measured in
control spheroids (Figure 8B–C); control spheroids were not
affected by the agonist (Figure 8B–C). In contrast to the effect with
the agonist, the S1PR1-specific blocker W146[36] significantly
stimulated the sprouting number and length of control HUVEC
spheroids, while its effects on the Memo KD spheroids were
minimal (Figure 8B–C). Moreover, sprouting of control HUVECs,
but not the Memo KD spheroids, was also stimulated with the
S1PR1/3 blocker VPC23019 (Figure S6B–C).
In summary, taken together these results suggest that there are
defects in S1PR1 signaling in Memo’s absence. Indeed, they
suggest that Memo plays a role in stabilizing junctional VE-
cadherin through the activation of S1P signaling in a cell-
autonomous manner. In its absence, junctions are destabilized and
increased sprouting of HUVEC multicellular spheroids was
observed.
Discussion
Our group identified Memo as an essential protein required for
breast cancer cell motility in response to RTKs. Memo KD tumor
cells showed decreased migration upon treatment with EGF, HRG
or FGF[1,2]. Mechanistically, we know that Memo is required for
localization of RhoA and mDia1 to the cell cortex, which
promotes microtubule (MT) outgrowth in cellular protrusions
and migration[37–39]. In the work presented here we uncovered a
novel role for Memo in S1P signaling. Our results from
experiments carried out with Memo null MEFs and Memo KD
HUVECs lead to the conclusion that Memo is required, either
directly or indirectly, for cell-autonomous S1PR signaling
(Figure 9). PDGF is well-known to require cell-autonomous
signaling of the SphK1/S1PR1 axis to induce migra-
tion[11,12,29]; our data clearly show that this pathway is not
active in cells lacking Memo. S1P is also known to be important
for endothelial cell proliferation and survival[18]. We show that in
conditions of serum-deprivation Memo KD HUVECs have
decreased survival and loss of junctional stability; both phenotypes
were rescued by exogenous S1P, also pointing to a problem with
cell-autonomous S1PR signaling in Memo’s absence. Considering
the importance of S1P signaling in numerous pathophysiological
processes[5–7], we think that the discovery of a novel player in this
pathway is very relevant.
One important feature of Memo KO/KD cells is that they have
no defect in the response to extracellular S1P or in the intracellular
production of S1P. Their response to S1P is intact with respect to
signaling pathway activation and migration. Furthermore, no
defect is observed in their basal intracellular S1P level. In Memo
KO MEFs, we have observed clear induction of intracellular S1P
level upon stimulation with PDGF. These results rule out the
possibility that Memo is required downstream of S1PRs or for the
activation of SphKs. How might Memo control cell-autonomous
S1PR signaling? The exact mechanism is still unknown, but based
on our results we favor a model in which Memo might regulate
access of intracellular S1P to the S1PR1 (Figure 9). In response to
PDGF treatment, control MEFs, but not the Memo KO MEFs
showed an increase in extracellular S1P levels. This suggests that
Memo loss somehow impairs transport of S1P, which is produced
and exported in a situation of acute RTK activation. However, in
the case of HUVECs in non-stimulated conditions, no difference
was detected in extracellular S1P levels between control and
Memo KD cultures. Given that both cellular systems, the MEFs
and the HUVECs, have defects in cell-autonomous S1PR
signaling, the results suggest that S1P transport that is Memo-
mediated, is not necessarily its release to the extracellular milieu.
The crystal structure of S1PR1[40] provides an interesting
explanation for such a process. The structural analysis suggests
that access to the ligand-binding pocket of S1PR1 could be
achieved from within the plasma membrane. This would allow
intracellular S1P to bind the receptor during transport from the
inner to the outer leaflet of the plasma membrane; extracellular
release might not be necessary[40]. Thus, Memo might be
Figure 6. Histological analyses of the vasculature in control
and Memo KO embryos. A, Whole-mount immunostaining with anti-
CD31 (PECAM-1) antibody on control and Memo KO yolk sacs at E13.5.
Scale bar, 500 mm. Representatives images of two different regions are
shown. B, Immunostaining with anti-smooth muscle actin (SMA)
antibody on dorsal aorta of control and Memo KO embryos at E14.5.
Note that the dorsal aorta of the Memo KO embryo was covered by a
layer of smooth muscle cells of the same width as control (indicated
with the markers of the same scale). Scale bar, 50 mm. C, Electron
microscopy micrographs (EM) of tight junctions (indicated as arrow-
heads) formed in limb bud capillary vessels in control and Memo KO
embryos at E12.5 (upper panel) and E13.5 (lower panel). Scale bar,
1 mm. Only Memo KO embryos with obvious abnormalities (pale yolk
sac and bleeding) were used for the analyses. In all images, Memo KO is
presented with the littermate control.
doi:10.1371/journal.pone.0094114.g006
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somehow involved in local transporting events that allow efficient
access of S1P to S1PR1. Further experimentation will be necessary
to test this hypothesis.
It has been shown in different cell types that the ABC family of
transporters is involved in S1P transport[9]; in endothelial cells the
non ATP-dependent transporter Spns2 has been shown to be
essential[41]. It is unlikely that Memo KO/KD impairs Spns2
since, as just mentioned, the levels of extracellular S1P are similar
in control and Memo KD HUVECs. Moreover there is no major
difference in S1P levels in Memo KO embryos; the lower levels
observed at E12.5, were recovered by E13.5 (Figure S4D) and
Memo ECKO null mice and control mice have similar levels of
plasma S1P (Figure S5C). These results are in contrast to the
Spns2 ECKO mice which show no lethal defect during
embryogenesis, but do display decreased plasma S1P levels[41,42].
We cannot rule out the possibility that Memo does have a role in
regulating some of the other ABC transporters.
Another interesting possibility to discuss is that Memo has a role
in coordinating events promoting S1P-S1PR1 binding by regulat-
ing localization of SphK1, S1P transporters, and S1PR1. It has
been proposed that their localization is coordinated with actin
dynamics through the function of an actin binding protein filamin
A[15]. Memo has been shown to have a role in coordinating the
dynamics of the microtubule and actin networks[37]. Although
recombinant purified Memo and SphK1 do not directly interact
(Figure S7B), we were able to pull-down complexes of Memo and
SphK1 from lysates of HEK293 cells transfected with Memo and
SphK1 expression vectors (Figure S7A). Thus, the observed defect
in cell-autonomous S1PR signaling might reflect defects in the
coordinated localization of SphK, S1P transporters and the
receptors.
The second important result presented in this manuscript is the
discovery that Memo is an essential gene for embryonic
development; all Memo 2/2 embryos died between E13.5 and
E18.5. Moreover, we show that Memo ECKO embryos have
features similar to the full KO, including edema and significant
bleeding. These observations indicate that Memo plays an
important role within endothelial cells and that vasculature defects
are likely to contribute to lethality, although an obvious reason for
the bleeding phenotype was not uncovered. The observed
phenotypes in Memo KO embryos and their timing of onset are
similar to what has been reported for S1PR1 KO and S1PR2/
S1PR3 double KO mice. S1PR1 KO embryos, however, have the
most severe phenotype, with prominent bleeding and defects in
aortic vascular smooth muscle cell coverage and rapid death. In
contrast, S1PR2/S1PR3 double KO mice show partial embryonic
Figure 7. The phenotypes of endothelial cell-specific Memo KO embryos. A, Schematic diagram for generating mice specifically lacking
Memo in endothelial cells. Tie2Cre tg/2::Memo +/2 males were mated with Memo floxed/floxed (fl/fl) females and the resulting Tie2Cre tg/2::Memo
fl/2 pups were analyzed as Memo endothelial cell-specific knock-out (ECKO) mice. B, Ratio of the genotypes of pups (n = 193) at postnatal day 21
(P21). The expected ratio of each genotype (25%) is indicated as a dashed line. C, Whole-mount view of control and Memo ECKO yolk sacs at E15.5.
Scale bar, 4 mm. D, Whole-mount view of control and Memo ECKO embryos from E14.5 to E16.5. The sites of edema and bleeding are indicated as
arrows and arrowheads, respectively. Scale bars, 4 mm. All Memo ECKO embryos shown in C and D were alive except for E16.5. In all images, Memo
KO is presented with the littermate control.
doi:10.1371/journal.pone.0094114.g007
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lethality and hemorrhaging, with no obvious defects in aortic
smooth muscle cell coverage[21], very likely reflecting compensa-
tion by S1PR1. It is tempting to speculate that in vivo Memo also
has an important role in S1P signaling during embryonic
development, however, we cannot link our ex vivo findings on
Memo’s involvement in cell-autonomous S1PR signaling with the
embryonic phenotypes. Despite the fact that the biological
significance of cell-autonomous S1PR signaling has been observed
in many cellular studies[6,10], including those shown here, the in
vivo contribution of this pathway to normal physiology has not
been conclusively shown. Erythrocytes and endothelial cells
provide S1P in the blood so that S1PRs are readily activated by
external sources [43,44]. Finally, it is worth mentioning that no
embryos survive beyond E18.5 in the absence of Memo, while
Figure 8. Defects in stabilization of VE-cadherin-mediated cellular junctions in Memo knock-down endothelial cells. A, Effects of S1P
or S1P receptor blocker on junctional localization of VE-cadherin in control and Memo KD HUVECs. Monolayers of HUVECs were cultured for 6 h in full
media or serum-free media with or without VPC23019 (1 mM) or S1P (1 mM), then fixed and stained for VE-cadherin. Scale bar, 40 mm. B–C, Sprout
formation from multicellular spheroids generated from control and Memo KD HUVECs. Sprouting was compared in the absence and presence of the
S1PR1-specific agonist, SEW2871 (100 nM) or the S1PR1-specific antagonist, W146 (10 mM). Representative images (B) and quantified results (C) are
shown. The numbers of multicellular spheroids used for each condition are indicated at the bottom of (C). Scale bar in (B), 100 mm. Data in (C) are
presented as means 6 S.D. of the scores for each multicellular spheroid. *, p,0.05; **, p,0.01; ***, p,0.001
doi:10.1371/journal.pone.0094114.g008
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Memo loss in endothelial cells is less severe, with ,50% of the
pups surviving. The embryonic lethal phenotype may reflect
Memo’s importance in other developmental processes. Memo has
been found associated with signaling from ErbB2[1], FGFR[4],
PDGFR (shown here) and IGF1R[45]. Each of these receptors
have essential developmental roles, however, none of the
phenotypes that we have found are similar to those described for
these receptors. Thus, the lethal phenotype we describe here is
likely to arise from a still to be identified role for Memo.
In conclusion, our data show that Memo has an important role
in cell-autonomous S1PR signaling. Future studies will be aimed at
further elucidation of the molecular basis of Memo’s role in cell-
autonomous S1PR signaling. S1P signaling is involved in different
diseases like autoimmunity or cancer and is predicted to be an
important therapeutic target. Indeed, several drugs targeting
SphKs, S1PRs or S1P are now under clinical investigation [46].
Our discovery of a new player in this pathway suggests that in the
future there might be additional options to target the S1PR
pathway.
Supporting Information
Figure S1 A, qPCR analysis for expression of Sphk1, Sphk2, S1pr1
and S1pr3 mRNA in control and Memo KO MEFs. Data were
normalized to the average value for the control and are presented
as means 6 S.D. of three RNA samples extracted from three
plates. B, SphK1 activity in control and Memo KO MEFs. Equal
amounts of cytoplasmic lysates from control and Memo KOMEFs
were analyzed for SphK1 activity. Data were normalized to the
average value for the control, which is set as 1, and are presented
as means 6 S.D. of samples from three individual plates. *, p,
0.05; **, p,0.01.
(TIF)
Figure S2 A, Transwell cell migration of control and Memo KD
HUVECs induced by VEGF (20 ng/ml). The data were
normalized to the average value for basal migration without
VEGF stimulation and are presented as means 6 S.D. of five
individual wells. B, Time course of VEGFR2 and ERK activation
after VEGF treatment of control and Memo KD HUVECs.
Monolayers of HUVECs was starved for 6 h and stimulated with
100 ng/ml VEGF for the indicated time. Cell lysates were
prepared and western analyses were performed with the indicated
antibodies; a-tubulin is the loading control.
(TIF)
Figure S3 A, Expression of Memo in mouse embryos. Lysates
were prepared from whole mouse embryos of the indicated stages
and western analyses were performed for Memo levels. B,
Detection of Memo mRNA in mouse embryos by in situ
hybridization. Sagittal sections of mouse embryos of the indicated
stages were hybridized with Memo antisense and sense (control)
riboprobe.
(TIF)
Figure S4 A, Schematic diagram for generating Memo KO
mice. Wild-type alleles in mouse ES cells were targeted with a
targeting construct containing a floxed NEO cassette and exon 2
(E2) of the mouse Memo gene. An ES clone containing the targeted
allele was selected and subsequently transfected with an expression
vector for Cre recombinase to delete the NEO cassette and E2 of
Memo. ES clones containing the deleted allele were selected and
used for chimera production. A mouse line giving germ-line
transmission with the ES clone was further bred as Memo +/2.
PCR primer F and R were used for genotyping. B, Genomic PCR
analysis for the Memo gene carried out on DNA extracted from
embryos from Memo +/2 intercrosses. The fragments amplified
from the wild-type (wt) and deleted (del) allele of Memo are
indicated. The three possible genotypes, i.e. +/+, +/2 and 2/2
are represented. C, Expression of Memo protein in control and
Memo KO embryos. Tissue extracts from whole embryos (E11.5)
with the indicated genotypes were prepared and western analyses
were performed for Memo. D, S1P levels in control and Memo
KO mouse embryos. S1P was extracted from whole embryos of
the indicated stages and analyzed by LC-ECI-MS/MS. Data are
presented as means 6 S.D. **, p,0.01.
(TIF)
Figure S5 A, Genomic PCR analysis of the Memo gene carried
out on ear DNA of the pups at P21. The fragments amplified from
the floxed (flox), wild-type (wt) and deleted (del) allele of the Memo
gene are indicated. The four possible genotypes i.e. 1) Memo fl/+
::Tie2Cre 2/2, 2) Memo fl/2::Tie2Cre 2/2, 3) Memo fl/+:: Tie2Cre
tg/2 and 4) Memo fl/2:: Tie2Cre tg/2 are represented. B, Body
weight of control and Memo ECKO mice. Data are presented as
means 6 S.E. C, S1P level in control and Memo KO mouse
plasma. S1P was extracted from plasma of adult mice (12-weeks
old) and analyzed by LC-ECI-MS/MS. Data are presented as
means 6 S.D. *, p,0.05; **, p,0.01; ***, p,0.001.
(TIF)
Figure S6 A, Expression of VE-cadherin in control and Memo
KD HUVECs after starvation. Monolayers of HUVECs were
cultured in serum-free media for 6 h. Cell lysates were prepared
and western analyses were performed with the indicated
antibodies. B–C, Sprout formation from multicellular spheroids
generated from control and Memo KD HUVECs. Sprouting was
compared in the absence and presence of VPC23019 (10 mM).
Representative images (B) and quantified results (C) are shown. A
part of the data shown in Figure 8B and 8C is shown again in
order to compare the effect of non-treated shLacZ and
shMemo#2 to VPC23019. The numbers of multicellular
spheroids used for each condition are indicated at the bottom of
(C). Scale bar in (B), 100 mm. Data in (C) are presented as means
6 S.D. of the scores for each multicellular spheroid. *, p,0.05; **,
p,0.01; ***, p,0.001.
(TIF)
Figure 9. Memo has an important role in cell-autonomous S1PR
signaling. S1PR1 can be activated by extracellular (red arrow) and
intracellular (blue arrow) S1P. Our in vitro data demonstrate that Memo
has an important role in the cell-autonomous pathway activating S1PR1
by intracellular S1P. In MEFs, absence of Memo results in a defect in cell-
autonomous activation of S1PR1 during cell migration induced by
PDGF. In HUVECs, knockdown of Memo results in defects in survival and
junction stabilization, both of which were rescued by addition of
exogenous S1P.
doi:10.1371/journal.pone.0094114.g009
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Figure S7 A, Complex formation between Memo and SphK1 in
HEK293T cells. Cells were transiently transfected with vectors
expressing myc-Memo and/or V5-SphK1. After 48 h, whole-cell
lysates (WCL) were prepared and subjected to immunoprecipita-
tion (IP) using either an anti-V5 or anti-myc antibody. Western
analyses were performed using the indicated antibodies. B,
Recombinant Memo and SphK1 do not directly interact.
Recombinant Memo (2 mg) or myc-Memo (2 mg) was incubated
with, or without, recombinant His-SphK1 (2 mg) and the protein
mixtures were subjected to pull-down assays using Ni-NTA
agarose. After washing, the bound proteins were eluted from the
agarose and western analyses were performed using the indicated
antibodies. 50 ng of each protein was loaded as a control.
(TIF)
Table S1 Primer pairs used for qPCR.
(PDF)
Table S2 Analysis of embryos from Memo +/2 inter-
crosses. Memo +/2 males and females were mated and the
genotype of the offspring at the indicated ages was analyzed. The
number of embryos with the indicated genotype are listed; the
numbers of dead embryos, as judged by the absence of a heartbeat
is in the (). * % live Memo 2/2/total live embryos.
(PDF)
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